This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

A Look At Childhood Cancer And African Americans

By the National Cancer Institute

Editor's Note:  The following article is part of the monthly Lifelines education and awareness print series that the National Cancer Institute provides to African American news and information outlets

BETHESDA, Md., Dec. 27, 2012 /PRNewswire-USNewswire/ -- Childhood cancer is rare—children with cancer account for less than 1 percent of all new cancer cases in the United States. But did you know that cancer is the second leading cause of death (after accidents) among children ages 1 to 14? It is estimated that in 2012 in the United States, more than 12,000 children (ages 0­ to 14) will be diagnosed with cancer and more than 1,300 will die from it.

(Logo: http://photos.prnewswire.com/prnh/20111018/DC89117LOGO)

But there is good news, too. Over the past 20 years, childhood cancer deaths overall have dropped, and many more children are surviving a cancer diagnosis. For example, only 58 percent of children ages 0 to 14 diagnosed in 1975–1977 lived at least 5 years after diagnosis, whereas it is estimated that more than 80 percent of those diagnosed today will make it to the 5-year mark. This improvement is due to remarkable advances in treatment and to the high participation of children with cancer in clinical trials.

Although African American children are less likely than white children to develop cancer, their 5-year survival rate is poorer, according to the National Cancer Institute's (NCI) Surveillance, Epidemiology, and End Results Program.

The most common types of childhood cancer are leukemias (blood cell cancers) and cancers of the brain and central nervous system. The causes of childhood cancers are largely unknown, and researchers are trying to learn about possible risk factors. You can learn more about childhood cancers at NCI's website. Just go to http://www.cancer.gov/cancertopics/types/childhoodcancers.

Despite the improvements in outcomes overall, some types of childhood cancer remain very difficult to treat and have low cure rates. NCI continues to try to find more effective treatments for all childhood cancers through research and clinical trials. If you have a child with cancer, have you thought about enrolling your child in a clinical trial? It is important to take the time to learn about cancer clinical trials and what benefits they may offer, even if you ultimately decide that a trial is not for your child. You can learn more about clinical trials at NCI's website. Just go to http://cancer.gov/clinicaltrials/learningabout.

Remember, when it comes to your child's health, knowing the facts and the options about treatment are critical. In the fight against cancer, clinical trials can offer hope and promise, but the only way to know whether a clinical trial is right for your child is to educate yourself and get the facts.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,691.98 -84.14 -0.47%
S&P 500 2,056.87 -11.02 -0.53%
NASDAQ 4,860.8480 -40.0370 -0.82%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs